Their study evaluated the relationship between irisin levels and a range of diabetic microvascular complications, including diabetic nephropathy, retinopathy, and neuropathy, and found that irisin levels were consistently reduced in patients with these chronic complications compared to those without (15, 35). This evidence concerns the gene FNDC5 and diabetic kidney disease.